Mackenzie Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Buy
87,745
+5,019
+6% +$128K ﹤0.01% 1018
2026
Q1
$2.07M Buy
82,726
+37,266
+82% +$882K ﹤0.01% 921
2025
Q4
$1.2M Sell
45,460
-10,917
-19% -$238K ﹤0.01% 1004
2025
Q3
$963K Buy
56,377
+35,022
+164% +$501K ﹤0.01% 1075
2025
Q2
$268K Buy
+21,355
New +$254K ﹤0.01% 1447

Other funds holding ZYME

Mackenzie Financial's ZYME Position: Q2 2026 in Review

Mackenzie Financial increased its Zymeworks (ZYME) stake by 6.1% in Q2 2026, buying an estimated $128K and bringing the position to 87,745 shares worth $2.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Mackenzie Financial first reported a position in ZYME in Q2 2025 and has held it in 5 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Mackenzie Financial held 87,745 shares of Zymeworks worth $2.29M as of Q2 2026.
  • Mackenzie Financial bought 5,019 Zymeworks shares in Q2 2026, an estimated $128K.
  • Zymeworks made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1018 holding.
  • Mackenzie Financial first reported a position in Zymeworks in Q2 2025 and has held it in 5 quarters since.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.